Avricore Health (AVCRF) Return on Equity (2014 - 2021)

Avricore Health (AVCRF) reported Return on Equity of 0.0% for Q4 2021, up 52.02% quarter-over-quarter from 0.0% in Q3 2021.

Avricore Health (AVCRF) Return on Equity (2014 - 2021) Analysis & Trends

Avricore Health (AVCRF) has 3 years of Return on Equity data on file, last reported at 0.0% in Q4 2021.

Return on Equity for Q4 2021 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was 0.0% (changed N/A YoY), and the FY2023 annual result was 0.0%, changed 0.0% from the prior year.
Return on Equity rose to 0.0% in Q4 2021 per AVCRF's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Equity peaked at 0.01% in Q4 2019 and troughed at 0.0% in Q1 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROE (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	0.00%
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	0.00%
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	0.00%
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	0.01%
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	0.00%
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	0.00%
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	0.00%
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	0.00%
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	-0.27%
10	Avricore Health	-	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2021	0.00%
Sep 30, 2021	0.00%
Jun 30, 2021	0.00%
Mar 31, 2021	0.00%
Dec 31, 2019	0.01%
Jun 30, 2014	0.00%